Biorithm envisions a world with better access to maternal care and improved outcomes for mother and child. To achieve this, Biorithm has developed a remote maternal-fetal care platform with novel intellectual property in device and algorithms.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/18/23 | $3,500,000 | Series A |
Adaptive Capital Partners SEEDS Capital | undisclosed |
